Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
doi 10.1186/s13075-019-1921-z
Full Text
Open PDFAbstract
Available in full text
Date
June 7, 2019
Authors
Publisher
Springer Science and Business Media LLC